Index S&P 500
P/E 69.91
EPS (ttm) 1.46
Insider Own 0.50%
Shs Outstand 198.00M
Perf Week 0.18%
Market Cap 20.24B
Forward P/E 25.77
EPS next Y 3.95
Insider Trans -27.49%
Shs Float 197.75M
Perf Month 8.64%
Income 290.80M
PEG 6.21
EPS next Q 0.83
Inst Own 99.73%
Short Float 1.25%
Perf Quarter 8.06%
Sales 3.67B
P/S 5.52
EPS this Y 10.80%
Inst Trans -1.06%
Short Ratio 2.25
Perf Half Y 26.48%
Book/sh 38.73
P/B 2.63
EPS next Y 11.37%
ROA 2.47%
Short Interest 2.48M
Perf Year 14.24%
Cash/sh 0.68
P/C 149.61
EPS next 5Y 11.25%
ROE 3.87%
52W Range 75.93 - 104.07
Perf YTD 7.64%
Dividend Est. -
P/FCF 148.84
EPS past 5Y 15.98%
ROI 2.79%
52W High -2.14%
Beta 0.93
Dividend TTM 0.03 (0.03%)
Quick Ratio 1.08
Sales past 5Y 7.68%
Gross Margin 60.91%
52W Low 34.11%
ATR (14) 1.84
Dividend Ex-Date Jul 26, 2023
Current Ratio 1.86
EPS Y/Y TTM -22.82%
Oper. Margin 14.64%
RSI (14) 59.29
Volatility 1.34% 1.73%
Employees 15000
Debt/Eq 0.36
Sales Y/Y TTM 8.48%
Profit Margin 7.93%
Recom 2.14
Target Price 108.57
Option/Short Yes / Yes
LT Debt/Eq 0.35
EPS Q/Q -4.56%
Payout -
Rel Volume 0.90
Prev Close 100.73
Sales Surprise 1.71%
EPS Surprise 8.49%
Sales Q/Q 8.51%
Earnings Feb 29 AMC
Avg Volume 1.10M
Price 101.84
SMA20 1.05%
SMA50 4.82%
SMA200 12.08%
Trades
Volume 986,332
Change 1.10%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-19-24 Upgrade
Redburn Atlantic
Neutral → Buy
$125
Mar-13-24 Upgrade
JP Morgan
Neutral → Overweight
$100 → $120
Feb-06-24 Resumed
KeyBanc Capital Markets
Sector Weight
Oct-30-23 Initiated
BofA Securities
Buy
$380
Oct-05-23 Downgrade
Redburn Atlantic
Overweight → Neutral
$390 → $343
May-30-23 Initiated
Morgan Stanley
Equal-Weight
$410
Dec-22-22 Initiated
Mizuho
Buy
$375
Nov-30-22 Upgrade
Robert W. Baird
Neutral → Outperform
$345 → $375
Oct-12-22 Downgrade
Jefferies
Buy → Hold
$400 → $295
Aug-29-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
May-17-22 Upgrade
Citigroup
Neutral → Buy
$460 → $405
Apr-08-22 Initiated
Needham
Hold
Jan-03-22 Upgrade
Guggenheim
Neutral → Buy
Sep-03-21 Reiterated
Stifel
Buy
$450 → $475
Sep-03-21 Reiterated
Oppenheimer
Perform
$405 → $475
Sep-03-21 Reiterated
KeyBanc Capital Markets
Overweight
$444 → $476
Sep-03-21 Reiterated
Citigroup
Neutral
$400 → $453
Apr-23-21 Initiated
Redburn
Buy
Jul-06-20 Downgrade
Robert W. Baird
Outperform → Neutral
$291
Mar-05-20 Initiated
Citigroup
Neutral
$360
Show Previous Ratings
Mar-25-24 02:16PM
Mar-11-24 08:27AM
Mar-08-24 02:37PM
Mar-01-24 10:41AM
(Morningstar Research) +9.18%
07:07AM
04:15PM
Loading…
Feb-29-24 04:15PM
Feb-26-24 09:16AM
Feb-22-24 10:00AM
Feb-21-24 08:01PM
Feb-20-24 11:35AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
Feb-13-24 09:43AM
Feb-12-24 10:31AM
08:02AM
08:31AM
Loading…
Feb-09-24 08:31AM
Jan-25-24 04:15PM
Jan-22-24 04:53AM
Jan-05-24 07:48AM
Dec-21-23 04:15PM
Dec-19-23 04:15PM
Dec-09-23 01:05AM
Dec-08-23 02:11PM
12:57PM
(Associated Press Finance)
09:17AM
09:14AM
07:15AM
(Thomson Reuters StreetEvents)
Dec-07-23 06:00PM
05:10PM
04:58PM
04:36PM
Loading…
04:36PM
(Associated Press Finance)
04:15PM
Dec-05-23 02:20PM
Dec-04-23 12:44PM
Nov-30-23 04:15PM
10:00AM
Nov-28-23 09:31AM
Nov-24-23 01:25AM
Nov-02-23 04:15PM
Nov-01-23 04:15PM
Oct-30-23 09:43AM
Oct-19-23 11:40AM
Oct-13-23 11:33AM
07:36AM
Sep-27-23 12:03PM
Sep-14-23 12:30PM
Sep-12-23 04:15PM
Sep-11-23 04:15PM
Sep-08-23 03:44PM
Sep-05-23 12:03PM
Aug-31-23 12:06PM
11:35AM
10:14AM
08:39AM
08:19AM
06:41AM
(Thomson Reuters StreetEvents)
Aug-30-23 06:00PM
06:00PM
05:25PM
04:25PM
04:15PM
Aug-29-23 08:46AM
Aug-28-23 11:43AM
Aug-25-23 08:02AM
Aug-24-23 12:10PM
Aug-15-23 03:41PM
Aug-13-23 08:23AM
Aug-10-23 09:05PM
Aug-09-23 06:46AM
Aug-07-23 01:18PM
Aug-02-23 04:14PM
Jul-27-23 04:33PM
Jul-26-23 04:15PM
Jul-17-23 07:05AM
04:37AM
Jul-13-23 02:00PM
10:00AM
Jul-12-23 04:15PM
11:40AM
Jul-03-23 10:30AM
Jun-28-23 10:19AM
Jun-23-23 11:40AM
Jun-21-23 08:00PM
Jun-15-23 07:52PM
Jun-09-23 07:13PM
Jun-07-23 11:40AM
Jun-06-23 03:39PM
Jun-05-23 09:35AM
07:21AM
Jun-02-23 05:45PM
02:07PM
(Thomson Reuters StreetEvents)
11:35AM
10:05AM
Jun-01-23 06:00PM
05:35PM
04:26PM
04:15PM
May-30-23 08:03AM
May-25-23 12:00PM
09:40AM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ricupati Agostino SVP & CAO Mar 18 '24 Option Exercise 69.74 54,724 3,816,317 34,609 Mar 20 06:58 PM Ricupati Agostino SVP & CAO Mar 18 '24 Sale 100.89 54,724 5,521,230 5,081 Mar 20 06:58 PM WEISS ROBERT S Director Mar 08 '24 Option Exercise 57.41 88,075 5,056,826 370,847 Mar 11 05:00 PM WEISS ROBERT S Director Mar 08 '24 Sale 102.18 88,075 8,999,732 282,772 Mar 11 05:00 PM WEISS ROBERT S Director Mar 07 '24 Option Exercise 57.41 153,213 8,796,724 435,985 Mar 11 05:00 PM WEISS ROBERT S Director Mar 07 '24 Sale 102.21 153,213 15,659,610 282,772 Mar 11 05:00 PM PETERSMEYER GARY S Director Mar 05 '24 Sale 103.51 1,000 103,506 5,668 Mar 07 06:05 PM Andrews Brian G EVP, CFO & Treasurer Jan 08 '24 Option Exercise 0.00 723 0 2,996 Jan 10 07:11 PM Warner Gerard H III President, CooperVision, Inc. Jan 08 '24 Option Exercise 0.00 2,738 0 4,028 Jan 10 07:11 PM McBride Daniel G EVP & Chief Operating Officer Jan 08 '24 Option Exercise 0.00 1,042 0 9,368 Jan 10 07:11 PM Ricupati Agostino SVP & CAO Jan 08 '24 Option Exercise 0.00 786 0 1,710 Jan 10 07:11 PM Khadder Nicholas VP, General Counsel & Corp Sec Jan 08 '24 Option Exercise 0.00 284 0 325 Jan 10 07:11 PM Sheffield Holly R President, CSI Jan 08 '24 Option Exercise 0.00 986 0 5,564 Jan 10 07:11 PM PETERSMEYER GARY S Director Jan 04 '24 Sale 336.03 150 50,404 2,297 Jan 05 06:05 PM WEISS ROBERT S Director Dec 19 '23 Option Exercise 175.31 79,370 13,914,355 150,063 Dec 21 05:25 PM WEISS ROBERT S Director Dec 19 '23 Sale 364.81 79,370 28,955,135 70,693 Dec 21 05:25 PM PETERSMEYER GARY S Director Dec 14 '23 Sale 368.55 300 110,565 2,464 Dec 14 07:15 PM Sheffield Holly R President, CSI Jun 04 '23 Option Exercise 356.47 1,104 393,543 4,952 Jun 07 02:45 PM PETERSMEYER GARY S Director Apr 01 '23 Option Exercise 0.00 630 0 2,764 Apr 03 06:30 PM Jay Colleen Director Apr 01 '23 Option Exercise 0.00 630 0 5,977 Apr 03 06:28 PM KOZY WILLIAM A Director Apr 01 '23 Option Exercise 0.00 662 0 6,314 Apr 03 06:29 PM Rivas Maria Director Apr 01 '23 Option Exercise 0.00 630 0 1,132 Apr 03 06:28 PM MADDEN TERESA S Director Apr 01 '23 Option Exercise 0.00 630 0 1,686 Apr 03 06:27 PM Lucchese Cynthia L Director Apr 01 '23 Option Exercise 0.00 512 0 512 Apr 03 06:25 PM WEISS ROBERT S Director Apr 01 '23 Option Exercise 0.00 693 0 70,693 Apr 03 06:31 PM Ricupati Agostino SVP & CAO Mar 31 '23 Sale 370.00 1,000 370,000 863 Apr 03 06:32 PM
Index RUT
P/E -
EPS (ttm) -0.45
Insider Own 2.30%
Shs Outstand 45.54M
Perf Week 4.69%
Market Cap 1.34B
Forward P/E 20.37
EPS next Y 1.44
Insider Trans 0.00%
Shs Float 44.86M
Perf Month 6.87%
Income -20.37M
PEG -
EPS next Q -0.09
Inst Own 99.01%
Short Float 5.10%
Perf Quarter -24.60%
Sales 1.15B
P/S 1.17
EPS this Y -44.10%
Inst Trans -2.70%
Short Ratio 3.98
Perf Half Y -35.85%
Book/sh 26.11
P/B 1.12
EPS next Y 34.43%
ROA -0.92%
Short Interest 2.29M
Perf Year -48.01%
Cash/sh 10.91
P/C 2.68
EPS next 5Y 12.00%
ROE -1.76%
52W Range 25.69 - 77.14
Perf YTD -22.30%
Dividend Est. -
P/FCF 9.62
EPS past 5Y -
ROI -1.14%
52W High -62.09%
Beta 0.75
Dividend TTM -
Quick Ratio 2.22
Sales past 5Y 10.40%
Gross Margin 43.58%
52W Low 13.82%
ATR (14) 1.13
Dividend Ex-Date -
Current Ratio 2.52
EPS Y/Y TTM -441.04%
Oper. Margin -1.00%
RSI (14) 56.27
Volatility 3.30% 3.75%
Employees 3650
Debt/Eq 0.52
Sales Y/Y TTM -11.48%
Profit Margin -1.78%
Recom 2.33
Target Price 33.29
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 50.30%
Payout 0.00%
Rel Volume 0.71
Prev Close 27.89
Sales Surprise 1.30%
EPS Surprise 114.42%
Sales Q/Q -13.04%
Earnings Feb 08 BMO
Avg Volume 574.96K
Price 29.24
SMA20 6.09%
SMA50 -1.03%
SMA200 -35.02%
Trades
Volume 410,594
Change 4.84%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-03-24 Initiated
Barclays
Underweight
$33
Nov-03-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$39 → $28
Nov-03-23 Upgrade
Piper Sandler
Neutral → Overweight
$70 → $39
Nov-03-23 Downgrade
BTIG Research
Buy → Neutral
Oct-11-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Sep-26-23 Reiterated
Wells Fargo
Underweight
$56 → $39
Aug-02-23 Downgrade
Piper Sandler
Overweight → Neutral
$66 → $70
Jul-20-23 Downgrade
Wells Fargo
Overweight → Underweight
$65 → $56
Feb-27-23 Upgrade
The Benchmark Company
Hold → Buy
$68
Nov-03-22 Downgrade
The Benchmark Company
Buy → Hold
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$130
Sep-09-22 Initiated
BofA Securities
Buy
$120
Jul-15-22 Initiated
SVB Leerink
Mkt Perform
$124
Dec-06-21 Resumed
Wells Fargo
Overweight
$203
Jun-09-21 Initiated
JP Morgan
Neutral
$146
May-24-21 Initiated
BTIG Research
Buy
$165
Feb-02-21 Upgrade
Piper Sandler
Neutral → Overweight
$86 → $147
Dec-08-20 Initiated
Berenberg
Buy
$145
Dec-03-20 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$95
Jul-07-20 Initiated
Stephens
Overweight
$90
Show Previous Ratings
Mar-27-24 07:49AM
07:38AM
Mar-19-24 04:27PM
Mar-11-24 05:11PM
Mar-01-24 08:43AM
05:15AM
Loading…
Feb-23-24 05:15AM
Feb-12-24 07:43AM
Feb-09-24 10:21AM
Feb-08-24 11:28PM
(Thomson Reuters StreetEvents) -10.35%
09:15AM
08:38AM
08:21AM
(Associated Press Finance)
08:00AM
Jan-16-24 04:01PM
Jan-11-24 04:00PM
12:51PM
Loading…
Jan-09-24 12:51PM
Jan-02-24 07:58AM
Dec-18-23 05:15AM
Dec-06-23 09:25AM
Nov-27-23 09:32AM
Nov-16-23 11:19AM
06:53AM
Nov-15-23 04:08AM
Nov-06-23 10:38AM
Nov-03-23 11:40AM
09:44AM
07:52AM
Nov-02-23 10:12AM
08:15AM
(Associated Press Finance)
08:10AM
08:01AM
Loading…
08:01AM
Oct-16-23 04:01PM
Sep-27-23 09:37AM
Sep-26-23 11:58AM
Sep-06-23 10:04AM
Sep-05-23 07:37PM
Sep-01-23 06:51PM
Aug-23-23 04:01PM
Aug-02-23 01:44PM
08:48AM
06:46AM
(Thomson Reuters StreetEvents)
Aug-01-23 05:25PM
04:24PM
04:01PM
Jul-20-23 10:01AM
Jul-12-23 04:01PM
Jul-11-23 08:30AM
Jun-21-23 08:00PM
Jun-01-23 03:00PM
11:31AM
May-30-23 04:01PM
May-18-23 01:09PM
May-15-23 04:01PM
May-09-23 10:51AM
May-03-23 04:01PM
08:24AM
(Thomson Reuters StreetEvents)
07:22AM
May-02-23 05:15PM
04:01PM
07:11AM
May-01-23 10:15AM
10:10AM
Apr-26-23 08:00PM
Apr-20-23 02:00PM
Apr-12-23 04:27PM
Apr-11-23 12:53PM
Apr-05-23 07:04AM
Mar-31-23 05:25PM
Mar-30-23 11:30AM
Mar-29-23 12:17PM
Mar-20-23 03:04AM
Mar-17-23 06:52AM
Mar-03-23 08:11PM
Mar-01-23 09:22AM
Feb-28-23 05:25PM
04:01PM
07:13AM
Feb-27-23 05:37AM
Feb-24-23 08:01AM
Feb-16-23 04:01PM
Feb-15-23 11:36AM
Feb-09-23 05:00AM
Feb-08-23 10:00AM
07:22AM
Feb-06-23 10:00AM
Jan-19-23 07:39AM
Jan-17-23 08:30AM
Jan-16-23 07:11AM
Jan-05-23 04:01PM
Jan-04-23 07:06AM
Jan-03-23 07:01AM
Dec-29-22 09:01AM
Dec-28-22 07:22AM
Dec-21-22 11:46AM
09:29AM
Dec-18-22 04:43PM
Dec-08-22 09:16AM
Dec-05-22 08:01AM
Nov-23-22 04:01PM
10:00AM
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MELLON CHRISTINE MARIE EVP, EXECUTIVE ADVISOR Jun 09 '23 Sale 73.14 7,951 581,568 14,876 Jun 12 04:04 PM LIPPS RANDALL A CHAIRMAN, PRESIDENT AND CEO Jun 08 '23 Buy 73.76 4,000 295,040 318,768 Jun 12 04:55 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite